Experienced in Transient Ischemic Attack (TIA)

Dr. Yogesh K. Paliwal

Cardiology
Indus Healthcare, Inc
2740 N Garey Ave, Suite 100, 
Pomona, CA 
Offers Telehealth
Experienced in Transient Ischemic Attack (TIA)
Indus Healthcare, Inc
2740 N Garey Ave, Suite 100, 
Pomona, CA 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Yogesh Paliwal is a Cardiologist in Pomona, California. Dr. Paliwal is rated as an Experienced provider by MediFind in the treatment of Transient Ischemic Attack (TIA). His top areas of expertise are Hypertension, Glucocorticoid-Remediable Aldosteronism, Hypertensive Heart Disease, Gastrostomy, and Endoscopy.

His clinical research consists of participating in 5 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Cardiology
Licenses
Internal Medicine in CA
Hospital Affiliations
San Antonio Regional Hospital
Chino Valley Medical Center
Montclair Hospital Medical Center
San Dimas Community Hospital
Emanate Health Inter-Community Hospital
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Alignment Health Plan
  • MEDICARE MAPD
  • MEDICARE SNP
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Blue Shield of California
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Health Net

Accepted plan types not found. Please verify directly with the provider.

Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Inland Empire Health Plan
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
Kaiser Permanente
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER MEDICARE
  • POS
  • PPO
LA Care
  • HMO
  • MANAGED MEDICAID PLAN
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
SCAN Health Plan
  • INSURANCE PLAN
  • MEDICARE MAPD
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 12 Less Insurance Carriers -

Locations

INDUS HEALTHCARE INC
2740 N Garey Ave, Suite 100, Pomona, CA 91767
Other Locations
INDUS HEALTHCARE INC
4950 San Bernardino St, Suite 202, Montclair, CA 91763
INDUS HEALTHCARE INC
333 N Sunset Ave, West Covina, CA 91790

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

5 Clinical Trials

A Phase 2, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of 2 mg and 4 mg SUVN-G3031 Compared to Placebo in Patients With Narcolepsy With and Without Cataplexy
A Phase 2, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of 2 mg and 4 mg SUVN-G3031 Compared to Placebo in Patients With Narcolepsy With and Without Cataplexy
Enrollment Status: Completed
Publish Date: January 13, 2025
Intervention Type: Drug
Study Drug: SUVN-G3031
Study Phase: Phase 2
A Phase 3, Randomized, Observer-Blinded, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Immunogenicity of a SARS-CoV-2 Recombinant Spike Protein Nanoparticle Vaccine (SARS-CoV-2 rS) With Matrix-M1™ Adjuvant in Adult Participants ≥ 18 Years With a Pediatric Expansion in Adolescents (12 to < 18 Years)
A Phase 3, Randomized, Observer-Blinded, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Immunogenicity of a SARS-CoV-2 Recombinant Spike Protein Nanoparticle Vaccine (SARS-CoV-2 rS) With Matrix-M1™ Adjuvant in Adult Participants ≥ 18 Years With a Pediatric Expansion in Adolescents (12 to < 18 Years)
Enrollment Status: Completed
Publish Date: December 21, 2023
Intervention Type: Biological, Other
Study Drug: SARS-CoV-2 rS/Matrix-M1 Adjuvant
Study Phase: Phase 3
AMPOWER A Single-arm, Phase III, Open Label, Multi-center, Study in Women Aged 18-35 Years of the Contraceptive Efficacy and Safety of Phexxi™ (Previously Referred to as AMPHORA®) Contraceptive Vaginal Gel
AMPOWER A Single-arm, Phase III, Open Label, Multi-center, Study in Women Aged 18-35 Years of the Contraceptive Efficacy and Safety of Phexxi™ (Previously Referred to as AMPHORA®) Contraceptive Vaginal Gel
Enrollment Status: Completed
Publish Date: September 17, 2020
Intervention Type: Drug
Study Phase: Phase 3
A Phase 2, Randomized, Multicenter, Double-Blind, Active and Vehicle Controlled Parallel-group Study Evaluating the Efficacy, Safety, and Tolerability of Products S6G5T-3 and S6G5T-1 for the Treatment of Acne Vulgaris for 12 Weeks
A Phase 2, Randomized, Multicenter, Double-Blind, Active and Vehicle Controlled Parallel-group Study Evaluating the Efficacy, Safety, and Tolerability of Products S6G5T-3 and S6G5T-1 for the Treatment of Acne Vulgaris for 12 Weeks
Enrollment Status: Completed
Publish Date: September 19, 2019
Intervention Type: Drug
Study Phase: Phase 2
A Randomized, Placebo-Controlled, Double-blind, Fixed-Dose, Multiple Cohort, Multiple Crossover, Dose-Finding Study of Oral BTD-001 in Adults With Idiopathic Hypersomnia (IH) or Narcolepsy Type 2
A Randomized, Placebo-Controlled, Double-blind, Fixed-Dose, Multiple Cohort, Multiple Crossover, Dose-Finding Study of Oral BTD-001 in Adults With Idiopathic Hypersomnia (IH) or Narcolepsy Type 2
Enrollment Status: Completed
Publish Date: January 16, 2019
Intervention Type: Drug
Study Phase: Phase 2
View 4 Less Clinical Trials
Similar Doctors
Gregg C. Fonarow
Elite in Transient Ischemic Attack (TIA)
Dr. Gregg C. Fonarow
Cardiology
Elite in Transient Ischemic Attack (TIA)
Dr. Gregg C. Fonarow
Cardiology

The Regents Of The University Of California

2020 Santa Monica Blvd, 
Santa Monica, CA 
 (42.1 miles away)
310-458-2381
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Gregg Fonarow is a Cardiologist in Santa Monica, California. Dr. Fonarow is rated as an Elite provider by MediFind in the treatment of Transient Ischemic Attack (TIA). His top areas of expertise are Heart Failure, Heart Attack, Atrial Fibrillation, Percutaneous Coronary Intervention (PCI), and Thrombectomy.

Distinguished in Transient Ischemic Attack (TIA)
Dr. Ronald P. Karlsberg
Cardiology | Interventional Cardiology
Distinguished in Transient Ischemic Attack (TIA)
Dr. Ronald P. Karlsberg
Cardiology | Interventional Cardiology

Cardiovascular Medical Group Of Southern California

8635 W 3rd St, Suite 1190w, 
Los Angeles, CA 
 (36.3 miles away)
310-652-4600
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Ronald Karlsberg is a Cardiologist and an Interventional Cardiologist in Los Angeles, California. Dr. Karlsberg is rated as a Distinguished provider by MediFind in the treatment of Transient Ischemic Attack (TIA). His top areas of expertise are Coronary Heart Disease, Atherosclerosis, Transient Ischemic Attack (TIA), High Cholesterol, and Heart Bypass Surgery.

Advanced in Transient Ischemic Attack (TIA)
Dr. Amritlal C. Ranavat
Cardiology
Advanced in Transient Ischemic Attack (TIA)
Dr. Amritlal C. Ranavat
Cardiology
1245 Wilshire Blvd, Suite 501, 
Los Angeles, CA 
 (29.8 miles away)
213-413-6196
Languages Spoken:
English
See accepted insurances

Amritlal Ranavat is a Cardiologist in Los Angeles, California. Dr. Ranavat is rated as an Advanced provider by MediFind in the treatment of Transient Ischemic Attack (TIA). His top areas of expertise are Transient Ischemic Attack (TIA), Heart Failure, Pulmonary Edema, and Mitral Valve Prolapse.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Paliwal's expertise for a condition
ConditionClose
    View All 22 Advanced Conditions
    View All 39 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile